Literature DB >> 18060658

Predictors of cognitive impairment and dementia in older people with diabetes.

D G Bruce1, W A Davis, G P Casey, S E Starkstein, R M Clarnette, J K Foster, O P Almeida, T M E Davis.   

Abstract

AIMS/HYPOTHESIS: Diabetes is associated with an increased risk of dementia but the reasons for this association are unclear because there are many potential mechanisms. We explored the relative contribution of diabetes-related variables as predictors of dementia in older individuals with diabetes.
METHODS: Survivors, aged > or =70 or more, were recruited from an existing observational cohort study 7.6 +/- 1.0 years after baseline, when they underwent a comprehensive assessment of diabetes, complications and cardiovascular risk factors. Dementia, probable Alzheimer's disease and cognitive impairment without dementia were diagnosed clinically. Logistic regression modelling determined independent predictors of cognitive diagnoses.
RESULTS: Of 302 participants, aged 75.7 +/- 4.6 years, 28 (9.3%) had dementia (16 with probable Alzheimer's disease) and 60 (19.9%) had cognitive impairment without dementia. The major independent longitudinal predictors of dementia were older age (per decade; odds ratio 4.0, 95% CI 1.59-10.10), diabetes duration (for each 5 years; odds ratio 1.69, 95% CI 1.24-2.32), peripheral arterial disease (odds ratio 5.35, 95% CI 2.08-13.72) and exercise (which was protective; odds ratio 0.26, 95% CI 0.09-0.73). For Alzheimer's disease, diabetes duration was an independent predictor in addition to age and diastolic blood pressure. The results of the cross-sectional analyses were similar with respect to diabetes duration and peripheral arterial disease. CONCLUSIONS/
INTERPRETATION: Peripheral arterial disease is a strong independent risk factor for dementia in diabetes. After adjustment for a wide range of potential risk factors, diabetes duration remains independently associated with dementia and probable Alzheimer's disease, indicating that factors not measured in this study may be important in the pathogenesis of dementia in diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060658     DOI: 10.1007/s00125-007-0894-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

Review 1.  The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.

Authors:  Eva Carro; Ignacio Torres-Aleman
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

Review 2.  Adiposity indices and dementia.

Authors:  Deborah Gustafson
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

3.  Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.

Authors:  T M Davis; P Zimmet; W A Davis; D G Bruce; S Fida; I R Mackay
Journal:  Diabet Med       Date:  2000-09       Impact factor: 4.359

4.  Five-year follow-up of cognitive impairment with no dementia.

Authors:  Holly Tuokko; Robert Frerichs; Janice Graham; Kenneth Rockwood; Betsy Kristjansson; John Fisk; Howard Bergman; Al Kozma; Ian McDowell
Journal:  Arch Neurol       Date:  2003-04

Review 5.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

7.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Authors:  C DeCarli; D Mungas; D Harvey; B Reed; M Weiner; H Chui; W Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

10.  Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study.

Authors:  T M E Davis; P Fortun; J Mulder; W A Davis; D G Bruce
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

View more
  40 in total

Review 1.  Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.

Authors:  A H Abdelhafiz; A J Sinclair
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

3.  Assessment of cognitive status in patients with type 2 diabetes through the Mini-Mental Status Examination: a cross-sectional study.

Authors:  Renata C Alencar; Roberta A Cobas; Marília B Gomes
Journal:  Diabetol Metab Syndr       Date:  2010-01-28       Impact factor: 3.320

Review 4.  Hypoglycemia in older people - a less well recognized risk factor for frailty.

Authors:  Ahmed H Abdelhafiz; Leocadio Rodríguez-Mañas; John E Morley; Alan J Sinclair
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

5.  Associations Between Ankle-Brachial Index and Cognitive Function: Results From the Lifestyle Interventions and Independence for Elders Trial.

Authors:  Mark A Espeland; Anne B Newman; Kaycee Sink; Thomas M Gill; Abby C King; Michael E Miller; Jack Guralnik; Jeff Katula; Timothy Church; Todd Manini; Kieran F Reid; Mary M McDermott
Journal:  J Am Med Dir Assoc       Date:  2015-04-11       Impact factor: 4.669

6.  Ankle-brachial index and inter-artery blood pressure differences as predictors of cognitive function in overweight and obese older adults with diabetes: results from the Action for Health in Diabetes movement and memory study.

Authors:  Mark A Espeland; Kristen M Beavers; Bethany Barone Gibbs; Karen C Johnson; Timothy M Hughes; Laura D Baker; John Jakicic; Mary Korytkowski; Marsha Miller; George A Bray
Journal:  Int J Geriatr Psychiatry       Date:  2014-12-26       Impact factor: 3.485

7.  Assessment of the cognitive status in diabetes mellitus.

Authors:  Shuba N
Journal:  J Clin Diagn Res       Date:  2012-09-12

8.  Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

Authors:  D G Bruce; W A Davis; G P Casey; R M Clarnette; S G A Brown; I G Jacobs; O P Almeida; T M E Davis
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122

9.  Depression in diabetes mellitus: a comprehensive review.

Authors:  E Andreoulakis; T Hyphantis; D Kandylis; A Iacovides
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

10.  Effect of Chinese herbal compound Naofucong () on the inflammatory process induced by high glucose in BV-2 cells.

Authors:  Guang-Chan Jing; Meng-Ren Zhang; Chao Ji; Ping-Ping Zuo; Yu-Qin Liu; Bei Gu
Journal:  Chin J Integr Med       Date:  2016-05-25       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.